Smarter, faster, better How AI is reshaping neuroscience clinical trials
By Fortrea
Download this whitepaper to learn how AI tools are beginning to support neuroscience sponsors in navigating a complex and high-risk field. Artificial intelligence could be a powerful lever to reduce costly delays in neuroscience clinical trials, bringing unprecedented precision, efficiency and insights to a difficult research domain. This whitepaper explores how AI could transform neurology trials, from streamlined protocol design to enhanced patient recruitment in pain studies and improved assessment accuracy in Parkinson’s.